UBS Group Increases Cardinal Health (NYSE:CAH) Price Target to $125.00

Cardinal Health (NYSE:CAH) had its target price upped by investment analysts at UBS Group from $120.00 to $125.00 in a research note issued to investors on Thursday, Benzinga reports. The firm presently has a “buy” rating on the stock. UBS Group’s target price suggests a potential upside of 15.74% from the company’s current price.

Other analysts also recently issued reports about the company. Robert W. Baird raised their price target on Cardinal Health from $130.00 to $137.00 and gave the stock an “outperform” rating in a research report on Thursday. Citigroup lowered their target price on shares of Cardinal Health from $115.00 to $107.00 and set a “neutral” rating for the company in a report on Friday, July 19th. Wells Fargo & Company cut their price target on shares of Cardinal Health from $96.00 to $94.00 and set an “underweight” rating on the stock in a report on Monday, April 29th. Evercore ISI raised their price objective on shares of Cardinal Health from $105.00 to $115.00 and gave the stock an “in-line” rating in a research note on Thursday. Finally, Argus dropped their target price on Cardinal Health from $120.00 to $115.00 and set a “buy” rating for the company in a research report on Wednesday, May 15th. One research analyst has rated the stock with a sell rating, five have given a hold rating and eight have issued a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $113.25.

Cardinal Health Stock Up 1.5 %

Shares of CAH stock opened at $108.00 on Thursday. The stock has a market cap of $26.31 billion, a P/E ratio of 48.00, a PEG ratio of 1.14 and a beta of 0.61. Cardinal Health has a 52 week low of $85.11 and a 52 week high of $116.04. The company’s fifty day simple moving average is $98.97 and its two-hundred day simple moving average is $103.18.

Cardinal Health (NYSE:CAH) last released its quarterly earnings data on Wednesday, August 14th. The company reported $1.84 EPS for the quarter, beating the consensus estimate of $1.72 by $0.12. The business had revenue of $59.87 billion during the quarter, compared to analyst estimates of $58.74 billion. Cardinal Health had a net margin of 0.25% and a negative return on equity of 54.74%. Cardinal Health’s quarterly revenue was up 12.1% compared to the same quarter last year. During the same quarter last year, the business earned $1.55 earnings per share. On average, analysts anticipate that Cardinal Health will post 7.35 EPS for the current fiscal year.

Institutional Investors Weigh In On Cardinal Health

Several hedge funds have recently made changes to their positions in the company. Norges Bank bought a new stake in shares of Cardinal Health in the fourth quarter valued at about $258,499,000. Point72 Asset Management L.P. bought a new position in shares of Cardinal Health during the second quarter valued at approximately $90,440,000. California Public Employees Retirement System increased its holdings in Cardinal Health by 118.9% during the fourth quarter. California Public Employees Retirement System now owns 1,516,035 shares of the company’s stock valued at $152,816,000 after buying an additional 823,520 shares during the period. Acadian Asset Management LLC raised its stake in Cardinal Health by 19.1% in the first quarter. Acadian Asset Management LLC now owns 3,723,159 shares of the company’s stock worth $416,585,000 after buying an additional 598,002 shares in the last quarter. Finally, Jupiter Asset Management Ltd. purchased a new stake in Cardinal Health during the first quarter worth $56,454,000. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.